非洲的肝细胞癌：挑战与机遇 - Suppr

Suppr

超能文献

Hepatocellular Carcinoma in Africa: Challenges and Opportunities.

作者信息

El-Kassas Mohamed, Elbadry Mohamed

机构信息

Department of Endemic Medicine, Faculty of Medicine, Helwan University, Cairo, Egypt.

出版信息

Front Med (Lausanne). 2022 Jun 24;9:899420. doi: 10.3389/fmed.2022.899420. eCollection 2022.

DOI:10.3389/fmed.2022.899420

PMID:35814750

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9263092/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7085/9263092/abc61b414b16/fmed-09-899420-g0001.jpg

相似文献

Hepatocellular Carcinoma in Africa: Challenges and Opportunities.

Front Med (Lausanne). 2022 Jun 24;9:899420. doi: 10.3389/fmed.2022.899420. eCollection 2022.

Hepatitis B virus infection and hepatocellular carcinoma in sub-Saharan Africa: Implications for elimination of viral hepatitis by 2030?

World J Gastroenterol. 2021 Sep 28;27(36):6025-6038. doi: 10.3748/wjg.v27.i36.6025.

Hepatocellular carcinoma: Epidemiology, pathogenesis and surveillance - implications for sub-Saharan Africa.

S Afr Med J. 2018 Aug 8;108(8b):35-40. doi: 10.7196/SAMJ.2018.v108i8b.13499.

Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma.

Pathol Biol (Paris). 2010 Aug;58(4):273-7. doi: 10.1016/j.patbio.2010.01.005. Epub 2010 Apr 7.

Epidemiology of Liver Cancer in Africa: Current and Future Trends.

Semin Liver Dis. 2020 May;40(2):111-123. doi: 10.1055/s-0039-3399566. Epub 2019 Nov 14.

Hepatitis C virus and HIV antibodies in patients with hepatocellular carcinoma in Zimbabwe: a pilot study.

Trans R Soc Trop Med Hyg. 1997 Sep-Oct;91(5):570-2. doi: 10.1016/s0035-9203(97)90029-8.

Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIV.

BMC Gastroenterol. 2020 Jul 13;20(1):226. doi: 10.1186/s12876-020-01372-2.

Synergistic effects of family history of hepatocellular carcinoma and hepatitis B virus infection on risk for incident hepatocellular carcinoma.

Clin Gastroenterol Hepatol. 2013 Dec;11(12):1636-45.e1-3. doi: 10.1016/j.cgh.2013.04.043. Epub 2013 May 10.

Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV/HCV infection.

JHEP Rep. 2021 Nov 24;4(2):100410. doi: 10.1016/j.jhepr.2021.100410. eCollection 2022 Feb.

Epidemiology, mutational landscape and staging of hepatocellular carcinoma.

Chin Clin Oncol. 2021 Feb;10(1):2. doi: 10.21037/cco-20-162.

引用本文的文献

Cancer immunotherapy clinical trials to support urgently needed access in low- and middle-income countries: a report from the SITC global access and impact committee.

J Immunother Cancer. 2025 Jun 22;13(6):e011258. doi: 10.1136/jitc-2024-011258.

Genetic polymorphisms as predictors of the response of hepatocellular carcinoma patients to doxorubicin chemotherapy: a genome-wide association study.

Front Pharmacol. 2025 Jun 4;16:1604473. doi: 10.3389/fphar.2025.1604473. eCollection 2025.

The Influence of CYP2B6, GSTP1, and SLCO1B1 Star Allele-Predicted Phenotypes and CBR1 Genetic Variants on Effectiveness Outcomes in Patients With Hepatocellular Carcinoma Receiving Doxorubicin via Transarterial Chemoembolization.

Pharmacol Res Perspect. 2025 Jun;13(3):e70114. doi: 10.1002/prp2.70114.

A public health call for action to address liver cancer and hepatitis in northern Ghana.

Commun Med (Lond). 2025 Apr 16;5(1):121. doi: 10.1038/s43856-025-00854-2.

Hepatitis C in North Africa: A Comprehensive Review of Epidemiology, Genotypic Diversity, and Hepatocellular Carcinoma.

Adv Virol. 2025 Mar 24;2025:9927410. doi: 10.1155/av/9927410. eCollection 2025.

Hepatitis B virus as a risk factor for hepatocellular carcinoma: There is still much work to do.

Liver Res. 2024 Jun 1;8(2):83-90. doi: 10.1016/j.livres.2024.05.004. eCollection 2024 Jun.

Chemopreventive potential of goniothalamin in diethylnitrosamine-induced hepatocellular carcinoma through the suppression of P13K/AKT signalling pathway.

Korean J Physiol Pharmacol. 2024 Nov 1;28(6):539-547. doi: 10.4196/kjpp.2024.28.6.539.

Copy Number Variation in the and Genes and the Risk of Liver Cirrhosis in Eastern Ethiopia.

Appl Clin Genet. 2023 Oct 20;16:171-179. doi: 10.2147/TACG.S435852. eCollection 2023.

Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes.

Cancer Rep (Hoboken). 2023 Sep;6 Suppl 1(Suppl 1):e1821. doi: 10.1002/cnr2.1821. Epub 2023 Jun 21.

The effect of metformin usage on survival outcomes for hepatocellular carcinoma patients with type 2 diabetes mellitus after curative therapy.

Front Endocrinol (Lausanne). 2022 Dec 13;13:1060768. doi: 10.3389/fendo.2022.1060768. eCollection 2022.

本文引用的文献

Time to complete hepatitis C cascade of care among patients identified during mass screening campaigns in rural Rwanda: a retrospective cohort study.

BMC Infect Dis. 2022 Mar 21;22(1):272. doi: 10.1186/s12879-022-07271-z.

Unique situation of hepatocellular carcinoma in Egypt: A review of epidemiology and control measures.

World J Gastrointest Oncol. 2021 Dec 15;13(12):1919-1938. doi: 10.4251/wjgo.v13.i12.1919.

Prevalence and incidence rates of laboratory-confirmed hepatitis B infection in South Africa, 2015 to 2019.

BMC Public Health. 2022 Jan 6;22(1):29. doi: 10.1186/s12889-021-12391-3.

Viral hepatitis associated hepatocellular carcinoma on the African continent, the past, present, and future: a systematic review.

BMC Cancer. 2021 Jun 19;21(1):715. doi: 10.1186/s12885-021-08426-y.

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.

Hepatocellular carcinoma.

Nat Rev Dis Primers. 2021 Jan 21;7(1):6. doi: 10.1038/s41572-020-00240-3.

A decade of hepatitis C at the University of Cape Town/Groote Schuur Hospital Liver Clinic, South Africa, in the pre-direct-acting antivirals era.

S Afr Med J. 2020 Jan 29;110(2):106-111. doi: 10.7196/SAMJ.2020.v110i2.14208.

A Systematic Review of the Current Hepatitis B Viral Infection and Hepatocellular Carcinoma Situation in Mediterranean Countries.

Biomed Res Int. 2020 Jun 10;2020:7027169. doi: 10.1155/2020/7027169. eCollection 2020.

Impact of treating chronic hepatitis C infection with direct-acting antivirals on the risk of hepatocellular carcinoma: The debate continues - A mini-review.

J Adv Res. 2019 Mar 7;17:43-48. doi: 10.1016/j.jare.2019.03.001. eCollection 2019 May.

Non-alcoholic fatty liver disease in Africa: a hidden danger.

Glob Health Epidemiol Genom. 2019 Apr 12;4:e3. doi: 10.1017/gheg.2019.2. eCollection 2019.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验